BioBiz Buzz offers exclusive insights into the biotech, pharma, and medtech industries through interviews with top executives and visionaries.
Providing thought-provoking podcasts covering topics such as scientific advancements, emerging technologies, and market trends, to keep listeners informed about the latest developments in life sciences.
Disclaimer
https://biobizbuzz.com/disclaimer/
29. From overlooked science to investable biotech: The 2026 Strüngmann Award.
What transforms a promising scientific opportunity into a viable biotechnology company? In this episode of BioBiz Buzz, Mike Ward speaks with Dr Jonathan Talbot, CEO of Melodia Therapeutics, co-founder and former CEO of Mosanna Therapeutics, and winner of the 2026 Strüngmann Award. The award recognises life-sciences entrepreneurs who combine scientific insight with the strategic and operational ability to translate innovation into successful products and companies. Jonathan Talbot expla...
In this episode of BioBiz Buzz, your host Mike Ward explores a critical, but often underappreciated, driver of vision loss in retinal diseases; the breakdown of the blood–retina barrier (BRB). While anti-VEGF therapies have transformed outcomes in diabetic macular oedema (DME) and wet age-related macular degeneration (AMD), many patients continue to experience incomplete responses, recurrence, and progressive vision loss; highlighting the limitations of therapies that primarily target downstr...
10 Jun 2026
27. Microbiome Medicines at Scale: MRM Health’s Mission to Redefine Immune-Mediated Disease
In this episode of BioBiz Buzz, Mike Ward talks to Dr Sam Possemiers, founder and CEO of Belgium-based MRM Health, about what it really takes to turn the human gut microbiome into a bona fide drug modality. They trace the arc from crude faecal microbiota transplants and limited single-strain probiotics to rationally designed consortia of commensal bacteria that function as a single, scalable therapeutic product. Moreover, Possemiers explains how MRM Health’s Coral platform starts with p...
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
Spotify
5.0 / 5
3 ratings
Podcast Authority Score: 22 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
31
Social presence
0
YouTube
0
Engagement
32
Host of BioBiz Buzz?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
